Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Blumea riparia" patented technology

An ainsliaea growth medium, tissue culture medium, tissue culture method and application

ActiveCN116836909Bpromote rootingImprove germplasm rooting ratePlant tissue cultureHorticulture methodsVitamin CSucrose
The application belongs to the technical field of plant cultivation and particularly relates to a Blumea riparia growth medium, a tissue culture medium, a tissue culture method and application. The Blumea riparia growth medium takes MS medium as a basic medium and further comprises 0.2-0.3 mg / L NAA, 0.08-0.16 mg / L DA-6, 10 mg / L vitamin C, 20 mg / L myo-inositol, 30 g / L sucrose and 6 g / L agar. DA-6 and NAA are jointly applied to improve the rooting efficiency, root length and plant height of Blumea riparia. The Blumea riparia germplasm with high content of levorotatory borneol is used as an explant to carry out tissue culture and seedling raising, the Blumea riparia tissue culture seedling has high content of levorotatory borneol, and Blumea riparia stable genetic good seedlings can be produced.
Owner:TROPICAL CORP STRAIN RESOURCE INST CHINESE ACAD OF TROPICAL AGRI SCI

Miao medicine composition for treating gouty arthritis as well as preparation method and application of Miao medicine composition

The invention discloses a Miao medicine composition for treating gouty arthritis as well as a preparation method and application thereof, and belongs to the technical field of Miao medicines. The Miao medicine composition comprises the following raw materials in parts by weight: 1-100 parts of blumea balsamifera, 1-50 parts of ixeris sonchifolia hance, 1-50 parts of Lijiang pseudobulbus cremastrae seu pleiones and 1-50 parts of pseudo-ginseng. The Miao medicine blumea balsamifera, ixeris sonchifolia hance, Lijiang pseudobulbus cremastrae seu pleiones and pseudo-ginseng serve as raw materials, a low-temperature production process serves as a main line, the effects of clearing away heat and toxic materials, relieving swelling and pain, cooling blood and stopping bleeding and the like of the Miao medicine are fully developed, and red swelling, blood stasis and local inflammation pain caused by gout can be effectively relieved. The four medicines are matched with one another to help a patient to relieve gout and accelerate the recovery process by promoting blood circulation to arrest pain and clearing heat and removing blood stasis. According to the whole-process low-temperature control production technology, medicine components in the Miao medicine are not impacted by high temperature, medicine effect components are fully reserved, the treatment effect is exerted to the maximum extent, and the treatment effect of the medicine is improved.
Owner:GUIZHOU MIAORENTANG PHARMACY CO LTD